GO:0033690 positive regulation of osteoblast proliferation: Signaling Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0033690 (positive regulation of osteoblast proliferation) describes any process that activates or increases the rate or extent of osteoblast proliferation, a central event in bone formation and skeletal homeostasis.
• Osteoblast proliferation is positively regulated by diverse cues including microbial metabolites such as butyrate, which acts through T regulatory cell-mediated WNT10B induction.
• Natural compounds and biomaterials, such as 7,3',4'-trimethoxyflavone and strontium-modified titanium surfaces, can directly stimulate osteoblast proliferation and function.
• Skeletal stem cells residing in the resting zone of the growth plate contribute to osteoblast supply, linking developmental skeletal stem cell biology to osteoblast proliferation control.
• Loss of negative regulators such as Atf7ip, which represses Sp7, enhances osteoblast differentiation and highlights the balance between positive and negative regulation.
• Single-cell transcriptomic atlases of bone metastases reveal osteoblast-related programs in the tumor microenvironment, underscoring the clinical relevance of osteoblast proliferation in cancer.
Description
Positive regulation of osteoblast proliferation (GO:0033690) is a biological process that encompasses any molecular or cellular event that activates or increases the rate or extent of osteoblast proliferation. Osteoblasts are the bone-forming cells responsible for synthesizing and mineralizing the bone matrix, and their proliferation is a prerequisite for adequate bone formation during development, growth, and adult bone remodeling. Understanding how this process is positively regulated is therefore fundamental to skeletal biology and to the development of therapies for bone loss and fracture repair. The term is defined in QuickGO as any process that activates or increases the rate or extent of osteoblast proliferation, and it sits within the broader ontology of bone development and remodeling. Research into GO:0033690 spans natural product pharmacology, microbial metabolite signaling, stem cell biology, and implant surface engineering. For example, the flavone 7,3',4'-trimethoxyflavone has been shown to positively regulate osteoblast proliferation and differentiation in MC3T3-E1 cells, while the short-chain fatty acid butyrate stimulates bone formation via T regulatory cell-mediated regulation of WNT10B expression. These findings illustrate that positive regulation of osteoblast proliferation can be driven by both exogenous chemical cues and endogenous immune-metabolic circuits. In translational contexts, enhancing osteoblast proliferation is a strategy for bone tissue regeneration, as reviewed for lactoferrin in bone tissue regeneration, and for improving osseointegration of dental and orthopedic implants through surface modification. At the same time, dysregulated osteoblast proliferation participates in pathological settings such as bone metastasis, where pan-cancer single-cell transcriptomic atlases have revealed osteoblast-like populations within the metastatic niche. Thus, GO:0033690 is a convergence point for developmental, pharmacological, and oncological research.
positive regulation of osteoblast proliferation At A Glance
| GO ID | GO:0033690 |
|---|---|
| GO term | positive regulation of osteoblast proliferation |
| Ontology | biological_process |
| Definition | Any process that activates or increases the rate or extent of osteoblast proliferation. |
| Synonym | activation of osteoblast proliferation; stimulation of osteoblast proliferation; up regulation of osteoblast proliferation; up-regulation of osteoblast proliferation; upregulation of osteoblast proliferation |
| Major function | Enhances the division of osteoblast lineage cells, supporting bone formation and skeletal homeostasis. |
| Related processes | Osteoblast differentiation, bone mineralization, WNT signaling, immune-metabolic regulation of bone. |
| Representative stimuli | 7,3',4'-trimethoxyflavone, butyrate, strontium-modified implant surfaces, lactoferrin. |
| Clinical relevance | Bone regeneration, implant osseointegration, bone metastasis, skeletal stem cell biology. |
What Is GO:0033690?
In our own words, GO:0033690 (positive regulation of osteoblast proliferation) refers to any biological process that activates or increases the rate or extent of osteoblast proliferation. It is a child of the broader regulation of osteoblast proliferation and is classified under biological_process in the Gene Ontology. The term captures upstream signals, receptors, intracellular cascades, and transcriptional programs that ultimately enhance the division of osteoblast lineage cells, without specifying the molecular mechanism. Synonyms include activation of osteoblast proliferation, stimulation of osteoblast proliferation, up regulation of osteoblast proliferation, up-regulation of osteoblast proliferation, and upregulation of osteoblast proliferation.
Why Is positive regulation of osteoblast proliferation Important in Cell Biology?
Positive regulation of osteoblast proliferation is important because osteoblasts are the only cells that build bone, and their proliferative expansion determines the number of matrix-synthesizing cells available for bone formation. Consequently, factors that positively regulate this process are attractive therapeutic candidates for fracture healing, osteoporosis, and bone tissue engineering. Conversely, understanding the positive regulators helps interpret pathological states such as bone metastasis, where osteoblast-lineage cells in the tumor microenvironment can influence disease progression. The term also connects to skeletal stem cell biology, since stem cell pools in the growth plate resting zone supply osteoblast precursors whose proliferation must be tightly controlled. Finally, negative regulators such as Atf7ip provide a counterbalance, and studying positive regulation in the context of such repressors clarifies the net signaling output.
• Osteoblast proliferation is a prerequisite for bone formation and skeletal growth.
• Positive regulators of osteoblast proliferation are candidate therapeutics for osteoporosis and fracture repair.
• Microbial metabolites such as butyrate can stimulate bone formation via immune-mediated WNT10B induction.
• Natural compounds like 7,3',4'-trimethoxyflavone directly enhance osteoblast proliferation in vitro.
• Implant surface modifications, such as strontium modification, can promote osteoblast functions for better osseointegration.
• Skeletal stem cells in the growth plate resting zone contribute to the osteoblast lineage and are relevant to proliferation control.
• Negative regulators such as Atf7ip modulate osteoblast differentiation by repressing Sp7, highlighting the importance of balanced regulation.
• Bone metastasis single-cell atlases reveal osteoblast-related programs in the tumor microenvironment.
• Lactoferrin has been reviewed as a promoter of bone tissue regeneration, linking positive regulation to translational applications.
• Understanding positive regulation supports the development of anabolic bone therapies.
What Happens During positive regulation of osteoblast proliferation?
Initiation by extracellular stimuli
In simple terms: Outside signals tell osteoblast precursors to start dividing.
Positive regulation of osteoblast proliferation begins when extracellular stimuli engage receptors or signaling complexes on osteoblast lineage cells. These stimuli include small molecules such as the flavone 7,3',4'-trimethoxyflavone, which has been shown to positively regulate osteoblast proliferation and differentiation in MC3T3-E1 cells. Microbial metabolites can also act as initiating cues; butyrate stimulates bone formation via T regulatory cell-mediated regulation of WNT10B expression, thereby promoting an anabolic program in bone. In addition, lactoferrin has been reviewed as a factor that supports bone tissue regeneration, consistent with a role in promoting osteoblast activity. These diverse inputs converge on the cell to trigger proliferative signaling.
Intracellular signaling and transcriptional activation
In simple terms: Signals inside the cell switch on genes that drive cell division.
Following receptor engagement, intracellular cascades activate transcription factors that drive proliferation-associated gene expression. WNT10B is a key mediator in this context, as its expression in bone is regulated by T regulatory cells in response to butyrate, leading to increased bone formation. The transcription factor Sp7 (Osterix) is essential for osteoblast differentiation and is negatively regulated by Atf7ip; relief of this repression enhances osteoblast differentiation, illustrating how transcriptional balance influences the osteoblast program. Positive regulation of proliferation therefore involves coordinated changes in gene expression that prepare the cell for division.
Cell cycle entry and proliferation
In simple terms: The cell commits to dividing and multiplies.
The ultimate outcome of positive regulation is increased entry into the cell cycle and enhanced proliferation of osteoblast lineage cells. This is observed experimentally when osteoblast-like cells such as MC3T3-E1 are treated with positive regulators and show increased proliferation. Similarly, strontium modification of titanium implant surfaces has been shown to positively regulate osteoblast functions, including proliferation, in the context of Porphyromonas gingivalis lipopolysaccharide stimulation. These examples demonstrate that positive regulation translates into measurable increases in osteoblast numbers.
Integration with skeletal stem cell supply
In simple terms: Stem cells provide new osteoblasts when needed.
Osteoblast proliferation does not occur in isolation; it is sustained by skeletal stem cell populations. The resting zone of the growth plate houses a unique class of skeletal stem cells that can give rise to osteoblast lineage cells. Positive regulation of osteoblast proliferation may therefore also involve signals that recruit or expand these stem cell pools, ensuring an adequate supply of proliferating osteoblast precursors during growth and repair.
Context-dependent modulation in disease
In simple terms: In disease, the same process can be hijacked or altered.
In pathological settings such as bone metastasis, osteoblast-lineage cells are present within the tumor microenvironment, as revealed by pan-cancer single-cell transcriptomic atlases of human bone metastases. This suggests that positive regulation of osteoblast proliferation can be influenced by cancer cells and may contribute to the metastatic niche. Understanding how the process is modulated in disease is essential for identifying therapeutic opportunities and avoiding unintended effects.
Key Genes Involved in GO:0033690 positive regulation of osteoblast proliferation
The following genes and proteins have been experimentally linked to positive regulation of osteoblast proliferation or closely related osteoblast functions in the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| WNT10B | WNT ligand induced by butyrate via T regulatory cells; promotes bone formation | Target for microbial metabolite-driven anabolic bone therapy |
| Sp7 (Osterix) | Master transcription factor for osteoblast differentiation; repressed by Atf7ip | Central node for transcriptional control of osteoblast programs |
| Atf7ip | Negative regulator of Sp7; its inhibition enhances osteoblast differentiation | Model for studying relief of repression to boost osteoblast function |
| DMBT1 | Exosomal protein from urine-derived stem cells; promotes angiogenesis in wound repair | Example of stem cell-derived factor with regenerative potential |
| MC3T3-E1 (cell model) | Osteoblast precursor cell line used to test positive regulators | Standard in vitro model for osteoblast proliferation assays |
| T regulatory cells (Tregs) | Immune cells mediating butyrate effects on WNT10B expression | Link between immune regulation and osteoblast proliferation |
| Skeletal stem cells (resting zone) | Unique stem cell class in growth plate resting zone supplying osteoblast lineage | Source of osteoblast precursors for proliferation studies |
| Lactoferrin | Iron-binding glycoprotein reviewed for bone tissue regeneration | Candidate anabolic factor for bone repair |
| Strontium (implant surface) | Modifies titanium surfaces to enhance osteoblast functions | Biomaterial strategy to positively regulate osteoblast proliferation |
| Porphyromonas gingivalis LPS | Inflammatory stimulus used to test osteoblast function on modified surfaces | Model for peri-implant inflammation and osteoblast response |
| 7,3',4'-Trimethoxyflavone | Natural flavone that positively regulates osteoblast proliferation and differentiation | Pharmacological tool to study osteoblast proliferation |
| Butyrate | Microbial metabolite that stimulates bone formation via Treg-WNT10B axis | Metabolic modulator of bone anabolism |
| Bone metastasis cells | Tumor cells in bone microenvironment with osteoblast-related programs | Context for pathological osteoblast proliferation |
| Urine-derived stem cells | Source of exosomal DMBT1 with pro-angiogenic effects | Regenerative cell source for bone and wound repair |
How Is positive regulation of osteoblast proliferation Regulated?
Positive regulation of osteoblast proliferation is controlled by a balance of stimulatory and inhibitory inputs. Butyrate, a microbial metabolite, stimulates bone formation through T regulatory cell-mediated regulation of WNT10B expression, providing an immune-metabolic layer of control. At the transcriptional level, Atf7ip inhibits osteoblast differentiation via negative regulation of the Sp7 transcription factor, meaning that relief of this inhibition can enhance the osteoblast program. Extracellular cues such as 7,3',4'-trimethoxyflavone can directly promote osteoblast proliferation in MC3T3-E1 cells, while biomaterial surface properties, such as strontium modification, can modulate osteoblast responses to inflammatory stimuli. Lactoferrin has been reviewed as a regulator of bone tissue regeneration, further highlighting the diversity of regulatory factors. Together, these mechanisms ensure that osteoblast proliferation is tightly regulated in space and time.
positive regulation of osteoblast proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| WNT10B | Bone formation and anabolic response to butyrate | Treg-osteoblast co-culture, butyrate treatment in vivo |
| Sp7 (Osterix) | Osteoblast differentiation disorders | Atf7ip knockout or knockdown in osteoblast cells |
| DMBT1 | Diabetic wound repair and angiogenesis | Exosome treatment in wound healing models |
| Skeletal stem cells | Growth plate and skeletal growth | Lineage tracing in mouse growth plate |
| Strontium-modified surface | Peri-implantitis and osseointegration | Titanium implant with P. gingivalis LPS stimulation |
Bone metastasis
Bone metastasis is a common complication of many cancers, and pan-cancer single-cell transcriptomic atlases of human bone metastases have revealed the presence of osteoblast-related cell populations within the metastatic microenvironment. Positive regulation of osteoblast proliferation may contribute to the reactive bone formation seen in some metastases, or may be subverted by tumor cells to support their growth. Understanding how osteoblast proliferation is regulated in this context could inform therapeutic strategies that target the bone niche.
Osteoporosis and bone loss
Conditions characterized by bone loss, such as osteoporosis, reflect an imbalance between bone formation and resorption. Positive regulators of osteoblast proliferation, including lactoferrin and butyrate, have been investigated for their potential to stimulate bone formation and regeneration. Enhancing osteoblast proliferation is therefore a rational anabolic strategy for treating bone loss.
Implant osseointegration and peri-implantitis
Dental and orthopedic implants require successful osseointegration, which depends on osteoblast function at the implant surface. Strontium modification of an SLA titanium implant surface has been shown to positively regulate osteoblast functions, including proliferation, even under stimulation with Porphyromonas gingivalis lipopolysaccharide, a model of peri-implant inflammation. This illustrates how material science can be used to promote osteoblast proliferation in clinically relevant scenarios.
Skeletal stem cell disorders
The resting zone of the growth plate houses a unique class of skeletal stem cells that contribute to bone growth. Dysregulation of these stem cells or of the signals that positively regulate osteoblast proliferation could contribute to skeletal growth disorders, although specific disease associations require further study.
From positive regulation of osteoblast proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene positively regulate osteoblast proliferation? | CRISPR knockout in MC3T3-E1 or primary osteoblasts followed by proliferation assays |
| Does a specific point mutation alter osteoblast proliferation? | CRISPR point mutation knock-in in osteoblast lineage cells |
| Can a therapeutic factor enhance osteoblast proliferation? | Overexpression of the factor or treatment with the compound in osteoblast cultures |
| How does a gene affect osteoblast differentiation and proliferation? | Knock-in of tagged protein for imaging and interaction studies |
| What is the role of a gene in bone metastasis? | Xenograft or syngeneic bone metastasis models with CRISPR-edited tumor cells |
| How do implant surfaces modulate osteoblast proliferation? | In vitro osteoblast culture on modified titanium surfaces |
How to Study the positive regulation of osteoblast proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| EdU/BrdU incorporation | DNA synthesis and cell proliferation | Quantifying osteoblast proliferation after treatment |
| CCK-8 or MTT assay | Metabolic activity and cell number | Screening positive regulators in MC3T3-E1 cells |
| RNA-seq | Global gene expression changes | Identifying pathways downstream of positive regulators |
| Single-cell RNA-seq | Cell-type-specific expression in tissues | Mapping osteoblast populations in bone metastasis |
| CRISPR knockout | Loss-of-function effects on proliferation | Testing necessity of candidate genes |
| CRISPR knock-in | Precise mutation or tag introduction | Studying point mutations or protein localization |
| In vivo bone formation assay | Bone volume and histology | Evaluating anabolic factors like butyrate |
| Implant surface culture | Osteoblast response to biomaterials | Testing strontium-modified titanium surfaces |
Cell proliferation assays
Proliferation of osteoblast lineage cells is commonly measured using colorimetric or fluorescent assays such as MTT, CCK-8, or EdU incorporation. These methods have been used to demonstrate that 7,3',4'-trimethoxyflavone positively regulates osteoblast proliferation in MC3T3-E1 cells and that strontium-modified surfaces enhance osteoblast functions. Such assays provide a direct readout of the positive regulation of osteoblast proliferation.
Transcriptomic and single-cell analysis
RNA sequencing and single-cell transcriptomics can reveal gene expression programs associated with osteoblast proliferation. Pan-cancer single-cell transcriptomic atlases of human bone metastases have identified osteoblast-related populations in the metastatic microenvironment. These approaches help identify novel positive regulators and their downstream targets.
Genetic perturbation with CRISPR
CRISPR-Cas9 knockout, point mutation, and knock-in strategies enable causal testing of candidate genes in osteoblast proliferation. For example, understanding the role of Atf7ip in repressing Sp7 can be advanced by generating loss-of-function mutations in osteoblast models. Such experiments establish whether a gene is necessary or sufficient for positive regulation of osteoblast proliferation.
In vivo bone formation models
Animal models, including butyrate supplementation studies and bone metastasis models, allow assessment of osteoblast proliferation in a physiological context. These models are essential for translating in vitro findings into potential therapies for bone regeneration and disease.
How CRISPR Can Be Used to Study GO:0033690 positive regulation of osteoblast proliferation
Knockout
CRISPR knockout of candidate positive regulators in osteoblast lineage cells can determine whether a gene is required for osteoblast proliferation. For example, knocking out Atf7ip, a negative regulator of Sp7, would be expected to enhance osteoblast differentiation, providing a test of its role in the regulatory network. Knockout studies in MC3T3-E1 cells or primary osteoblasts followed by proliferation assays can establish causality.
Point Mutation
CRISPR point mutation knock-in allows the introduction of specific amino acid changes to study structure-function relationships in proteins that regulate osteoblast proliferation. This approach is valuable for dissecting domains of transcription factors such as Sp7 or signaling molecules like WNT10B. Point mutations can reveal phosphorylation sites or interaction surfaces critical for positive regulation.
Knock-in
Knock-in of reporter genes or epitope tags enables visualization and quantification of proteins involved in osteoblast proliferation. Tagging endogenous Sp7 or WNT10B would allow tracking of their expression and localization in response to stimuli such as butyrate or flavones. Knock-in models also facilitate the study of gene dosage effects in bone formation.
Overexpression
Overexpression of positive regulators, such as WNT10B or lactoferrin, can test sufficiency for enhancing osteoblast proliferation and bone formation. Overexpression models are particularly useful for validating therapeutic candidates identified from screening studies.
How EDITGENE Supports positive regulation of osteoblast proliferation Research
Researchers studying positive regulation of osteoblast proliferation-related genes often need to determine whether a candidate gene is causally involved in the process, and CRISPR-based models provide the most direct way to establish such causality. EDITGENE offers a comprehensive suite of services to support these investigations.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of osteoblast proliferation research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| BMP2 Knockout HEK293 Cell Line | EDJ-KQ367 | Human | 650 | Details Get a Quote |
| ITGB3 Knockout HEK293 Cell Line | EDJ-KQ818 | Human | 3690 | Details Get a Quote |
| HPSE Knockout HEK293 Cell Line | EDJ-KQ2346 | Human | 10855 | Details Get a Quote |
| CCN1 Knockout HEK293 Cell Line | EDJ-KQ2990 | Human | 3491 | Details Get a Quote |
| LTF Knockout HEK293 Cell Line | EDJ-KQ5151 | Human | 4057 | Details Get a Quote |
| FBLN5 Knockout HEK293 Cell Line | EDJ-KQ7074 | Human | 10516 | Details Get a Quote |
| SOX8 Knockout HEK293 Cell Line | EDJ-KQ9177 | Human | 30812 | Details Get a Quote |
| TMEM119 Knockout HEK293 Cell Line | EDJ-KQ15791 | Human | 338773 | Details Get a Quote |
| CCN1 Knockout A-549 Cell Line | EDJ-KQ24170 | Human | 3491 | Details Get a Quote |
| CCN1 Knockout HCT 116 Cell Line | EDJ-KQ24171 | Human | 3491 | Details Get a Quote |
| CCN1 Knockout HeLa Cell Line | EDJ-KQ24172 | Human | 3491 | Details Get a Quote |
| ITGB3 Knockout HeLa Cell Line | EDJ-KQ18290 | Human | 3690 | Details Get a Quote |
| BMP2 Knockout HeLa Cell Line | EDJ-KQ18558 | Human | 650 | Details Get a Quote |
| HPSE Knockout A-549 Cell Line | EDJ-KQ22770 | Human | 10855 | Details Get a Quote |
| HPSE Knockout HCT 116 Cell Line | EDJ-KQ22771 | Human | 10855 | Details Get a Quote |
Displaying Records 1 To 15 Of 32 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About positive regulation of osteoblast proliferation
What is GO:0033690 positive regulation of osteoblast proliferation?
GO:0033690 is a Gene Ontology biological process term defined as any process that activates or increases the rate or extent of osteoblast proliferation.
What genes are involved in positive regulation of osteoblast proliferation?
Genes and factors experimentally linked to this process include WNT10B, Sp7 (Osterix), Atf7ip, and DMBT1, as well as exogenous stimuli like butyrate and 7,3',4'-trimethoxyflavone.
How is osteoblast proliferation positively regulated?
It is positively regulated by extracellular stimuli such as flavones, microbial metabolites like butyrate, and biomaterial surface modifications, which activate intracellular signaling and transcriptional programs.
What is the role of WNT10B in osteoblast proliferation?
WNT10B is a WNT ligand whose expression in bone is regulated by T regulatory cells in response to butyrate, leading to stimulated bone formation.
How does butyrate affect osteoblast proliferation?
Butyrate stimulates bone formation via T regulatory cell-mediated regulation of WNT10B expression, thereby promoting an anabolic bone program.
What cell models are used to study positive regulation of osteoblast proliferation?
MC3T3-E1 cells are a widely used osteoblast precursor model for testing positive regulators such as 7,3',4'-trimethoxyflavone.
Can CRISPR be used to study osteoblast proliferation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes involved in positive regulation of osteoblast proliferation.
What diseases are associated with osteoblast proliferation?
Bone metastasis, osteoporosis, and peri-implantitis are among the conditions where osteoblast proliferation and its regulation are relevant.
How do implants affect osteoblast proliferation?
Strontium modification of titanium implant surfaces has been shown to positively regulate osteoblast functions, including proliferation, even under inflammatory stimulation.
What methods measure osteoblast proliferation?
Common methods include EdU/BrdU incorporation, CCK-8, and MTT assays, as well as transcriptomic and single-cell approaches.
Conclusion
GO:0033690 positive regulation of osteoblast proliferation is a fundamental biological process that governs the expansion of bone-forming cells. Research has identified diverse positive regulators, from natural compounds and microbial metabolites to immune signals and biomaterial surfaces, all converging on enhanced osteoblast proliferation. Understanding these mechanisms is essential for developing anabolic therapies for bone loss and for interpreting pathological contexts such as bone metastasis. Continued investigation using CRISPR-based models and advanced omics will further clarify the regulatory networks that control osteoblast proliferation.
References
- 1. Fayyaz S et al.. 2024. Positive Regulation of Osteoblast Proliferation and Differentiation in MC3T3- E1 Cells by 7,3',4'-Trimethoxyflavone.. Curr Mol Pharmacol 17:e18761429305367 PMID: 39129721
- 2. Wang S et al.. 2026. A pan-cancer single-cell transcriptomic atlas of human bone metastases.. Cell Rep Med 7(2):102583 PMID: 41619722
- 3. Chen CY et al.. 2018. Exosomal DMBT1 from human urine-derived stem cells facilitates diabetic wound repair by promoting angiogenesis.. Theranostics 8(6):1607-1623 PMID: 29556344
- 4. Tyagi AM et al.. 2018. The Microbial Metabolite Butyrate Stimulates Bone Formation via T Regulatory Cell-Mediated Regulation of WNT10B Expression.. Immunity 49(6):1116-1131.e7 PMID: 30446387
- 5. Mizuhashi K et al.. 2018. Resting zone of the growth plate houses a unique class of skeletal stem cells.. Nature 563(7730):254-258 PMID: 30401834
- 6. Hu G et al.. 2023. Atf7ip Inhibits Osteoblast Differentiation via Negative Regulation of the Sp7 Transcription Factor.. Int J Mol Sci 24(5) PMID: 36901736
- 7. Icriverzi M et al.. 2020. Lactoferrin in Bone Tissue Regeneration.. Curr Med Chem 27(6):838-853 PMID: 31258057
- 8. Park JW. 2020. Positive regulation of Porphyromonas gingivalis lipopolysaccharide-stimulated osteoblast functions by strontium modification of an SLA titanium implant surface.. J Biomater Appl 34(6):802-811 PMID: 31558092
